Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS DPhil & MSc by Research

Project Outline

A major challenge for the treatment of immune-mediated inflammatory diseases is to understand factors which determine the balance between pro- and anti-inflammatory activity of lymphoid and myeloid subsets. Several tryptophan catabolites (kynurenines) have been shown to modulate immune cell function and we have shown that the first enzyme of the kynurenine pathway, indoleamine-2,3-dioxygenase (IDO), inhibits the development of arthritis [1] and atherosclerosis [2] in animal models along with a suppression of Th17 cells. Thus, administration of kynurenine improved symptoms whereas the elimination of IDO exacerbated them. Indeed, it has previously been reported that regulatory T (Treg) cells are defective in RA and we showed that this defect is caused by down-regulation of CTLA-4 on Treg cells, resulting in an inability to activate the KP [3]. Other catabolites, such as 3-hydroxy-anthranilic acid (3HAA), can potentiate the reduction by IDO-positive dendritic cells of IFN-ɣ production by T cells, with an increased production of the anti-inflammatory cytokine, IL-10. IDO activation and kynurenine catabolites also promote the generation of FoxP3+ CD4+CD25+ Treg cells which induce IDO expression in dendritic cells which further promotes Treg cell responses. The aim of the project is to understand the regulation of immune cell function by kynurenines in the context of inflammatory disease.

The project will investigate

(a) the efficacy of ligands acting on Dicarboxylic Amino Acid Receptors [DAARs, responding to N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) or kainate]

(b) the activity of tryptophan catabolites in the kynurenine pathway known to act on these receptors in the nervous system

(c) the existence of interactions (synergistic or antagonistic) between these compounds

(d) the involvement of related receptors such as aryl hydrocarbon receptors (AHR), hydroxy-carboxylate receptors or GPR35 sites

(e) the effects of test compounds on the viability and functionality of leukocytes bearing the above receptors (differentiation, proliferation, apoptosis, chemotaxis)

(f) the effects of selected compounds on disease activity in animal models

The results will contribute to understanding cellular functions underlying the generation, maintenance and resolution of inflammatory conditions.

T cells and monocytes will be isolated from human blood and exposed to recognised DAAR ligands and compounds from the oxidative metabolism of tryptophan, including kynurenine, kynurenic acid, 3-hydroxykynurenine, 3-hydroxy-anthranilic acid (3HAA), cinnabarinic acid, picolinic acid and quinolinic acid. Functional changes in the activity of these cells will be examined as follows.

a) proliferation, as measured by incorporation of bromodeoxyuridine.

b) differentiation into functionally distinct subsets (e.g. Th1, Th2, Th17 or Treg cells).

c) spontaneous migration

d) chemotaxis

e) cytokine expression

Training Opportunities

The Kennedy Institute is a world-renowned research centre and is housed in a brand new state-of-the-art research facility. Students will use a variety of in vitro molecular and cellular methods (e.g. RT-PCR, FACS, Western blotting, ELISAs, cell migration assays), as well as in vivo models (e.g. collagen-Induced Arthritis). Receptor silencing or modification using siRNA or CRISPR modifications will be used for more detailed analysis of receptor function. A core curriculum of lectures will be taken in the first term to provide a solid foundation in a broad range of subjects including musculoskeletal biology, inflammation, epigenetics, translational immunology, data analysis and the microbiome. Students will attend regular seminars within the department and those relevant in the wider University. Students will be expected to present data regularly in lab meetings and departmental seminars, and to attend external conferences to present their research globally. Students will have access to various courses run by the Medical Sciences Division Skills Training Team and other departments. All students are required to attend a 2-day Statistical and Experimental Design course at NDORMS.

How to Apply

The department accepts applications throughout the year but it is recommended that, in the first instance, you contact the relevant supervisors or the Graduate Studies Officer, Sam Burnell (Samuel.burnell@ndorms.ox.ac.uk), who will be able to advise you of the essential requirements. Interested applicants should have or expect to obtain a first or upper second class BSc degree or equivalent, and will also need to provide evidence of English language competence. The application guide and form is found online and the DPhil or MSc by research will commence in October 2019. For further information, please visit http://www.ox.ac.uk/admissions/graduate/applying-to-oxford.

Publications

  • Criado G, Simelyte E, Inglis JJ, Essex D, Williams RO: Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 2009, 60(5):1342-1351.
  • Cole JE, Astola N, Cribbs AP, Goddard ME, Park I, Green P, Davies AH, Williams RO, Feldmann M, Monaco C: Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proc Natl Acad Sci U S A 2015, 112(42):13033-13038.
  • Cribbs AP, Kennedy A, Penn H, Read JE, Amjadi P, Green P, Syed K, Manka SW, Brennan FM, Gregory B et al: Regulatory T cell function in rheumatoid arthritis is compromised by CTLA-4 promoter methylation resulting in a failure to activate the IDO pathway. Arthritis Rheumatol 2014, 66:2344-2354.

Further information

Contact: Richard Williams, Kennedy Institute of Rheumatology, University of Oxford (richard.williams@kennedy.ox.ac.uk) or Trevor Stone, Kennedy Institute of Rheumatology, University of Oxford (trevor.stone@kennedy.ox.ac.uk)

Co-supervisor

Trevor Stone

 

Project reference number #NDORMS-2019/13

PROJECTS

Full list

STUDY WITH US

Find out more